Thoracoscopy and talc poudrage in the management of hepatic hydrothorax

被引:96
作者
de Campos, JRM
Andrade, LO
Werebe, ED
Sette, H
Fernandez, A
Filomeno, LTB
Jatene, FB
机构
[1] Hosp Israelita Albert Einstein, Div Thorac Surg, Sao Paulo, Brazil
[2] Hosp Israelita Albert Einstein, Div Hepatol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med, Hosp Clin, Sao Paulo, Brazil
关键词
hepatic hydorthorax; pleurodesis; talc poudrage; thoracoscopy;
D O I
10.1378/chest.118.1.13
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To determine indications, limitations, morbidity and mortality of surgical thoracoscopy for management of hepatic hydrothorax, a rare, but often recurrent, complication in cirrhotic patients. Patients and methods: From May 1985 through May 1999, 10 men and 8 women, with a mean age of 57.6 years (range, 26 to 76 years), underwent 21 therapeutic thoracoscopies to achieve pleurodesis by application of talc. Results: The procedure was effective in 10 of 21 procedures. There were four recurrences (19.1%) that were retreated, with only one being successful. In this specific group, we detected high morbidity (57.1%) and mortality (38.9%) during the follow-up period of 3 months, Diaphragmatic defects were localized and closed five times (23.8%). Hospital stay was approximately 15 days (range, 5 to 41 days). Conclusion: The procedure appears to be indicated for these fragile patients, especially when medical therapy fails. Immediate efficacy was 47.6%, increasing to 60% with videothoracoscopy and suture of the diaphragmatic defect, However, morbidity and mortality were high.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 26 条
[1]   HEPATIC HYDROTHORAX - CAUSE AND MANAGEMENT [J].
ALBERTS, WM ;
SALEM, AJ ;
SOLOMON, DA ;
BOYCE, G .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (12) :2383-2388
[2]  
BISCEGLIE M, 1996, ANN THORAC SURG, V62, P1509
[3]  
Colombo A, 1992, Minerva Med, V83, P219
[4]   SCINTIGRAPHIC DIAGNOSIS OF PERITONEO-PLEURAL COMMUNICATION IN THE ABSENCE OF ASCITES [J].
DALY, JJ ;
POTTS, JM ;
GORDON, L ;
BUSE, MG .
CLINICAL NUCLEAR MEDICINE, 1994, 19 (10) :892-894
[5]   Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt [J].
Degawa, M ;
Hamasaki, K ;
Yano, K ;
Nakao, K ;
Kato, Y ;
Sakamoto, I ;
Nakata, K ;
Eguchi, K .
JOURNAL OF GASTROENTEROLOGY, 1999, 34 (01) :128-131
[6]  
FALCHUK KR, 1977, GASTROENTEROLOGY, V72, P319
[7]   Hepatic hydrothorax - Diagnosis and management [J].
Giacobbe, A ;
Facciorusso, D ;
Barbano, F ;
Andriulli, A ;
Frusciante, V .
CLINICAL NUCLEAR MEDICINE, 1996, 21 (01) :56-60
[8]   The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt [J].
Gordon, FD ;
Anastopoulos, HT ;
Crenshaw, W ;
Gilchrist, B ;
McEniff, N ;
Falchuk, KR ;
LoCicero, J ;
Lewis, WD ;
Jenkins, RL ;
Trey, C .
HEPATOLOGY, 1997, 25 (06) :1366-1369
[9]  
HAITJEMA TJ, 1994, NETH J MED, V44, P207
[10]   Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax [J].
Jeffries, MA ;
Kazanjian, S ;
Wilson, M ;
Punch, J ;
Fontana, RJ .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (05) :416-423